Royal Bank of Canada
VIVO

Royal Bank of Canada’s Meridian Bioscience Inc VIVO Stock Holding History

Royal Bank of Canada’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-16,910
Closed -$562K – 7818
2022
Q4 		$562K Buy
16,910
+1,085
+7% +$34.9K ﹤0.01% 4008
2022
Q3 		$499K Sell
15,825
-26,751
-63% -$866K ﹤0.01% 4043
2022
Q2 		$1.29M Buy
42,576
+23,980
+129% +$649K ﹤0.01% 3267
2022
Q1 		$482K Sell
18,596
-3,482
-16% -$82.8K ﹤0.01% 4309
2021
Q4 		$451K Buy
22,078
+5,065
+30% +$97.1K ﹤0.01% 4563
2021
Q3 		$327K Buy
17,013
+889
+6% +$17.7K ﹤0.01% 4711
2021
Q2 		$358K Buy
16,124
+320
+2% +$6.79K ﹤0.01% 4569
2021
Q1 		$415K Sell
15,804
-18,022
-53% -$429K ﹤0.01% 4348
2020
Q4 		$633K Sell
33,826
-57,563
-63% -$1.07M ﹤0.01% 3926
2020
Q3 		$1.55M Buy
91,389
+56,082
+159% +$1.09M ﹤0.01% 2909
2020
Q2 		$823K Buy
35,307
+3,521
+11% +$51K ﹤0.01% 3343
2020
Q1 		$268K Sell
31,786
-40,188
-56% -$338K ﹤0.01% 4120
2019
Q4 		$703K Sell
71,974
-1,100
-2% -$10.3K ﹤0.01% 3727
2019
Q3 		$693K Sell
73,074
-2,697
-4% -$28.4K ﹤0.01% 3624
2019
Q2 		$900K Buy
75,771
+22,910
+43% +$276K ﹤0.01% 3393
2019
Q1 		$931K Buy
52,861
+4,366
+9% +$72.6K ﹤0.01% 3250
2018
Q4 		$842K Sell
48,495
-4,565
-9% -$77.9K ﹤0.01% 3299
2018
Q3 		$784K Buy
53,060
+1,885
+4% +$29.2K ﹤0.01% 3557
2018
Q2 		$813K Buy
51,175
+1,898
+4% +$28.3K ﹤0.01% 3396
2018
Q1 		$700K Buy
49,277
+1,860
+4% +$27.5K ﹤0.01% 3445
2017
Q4 		$664K Sell
47,417
-4,155
-8% -$60.8K ﹤0.01% 3580
2017
Q3 		$737K Buy
51,572
+2,656
+5% +$37.9K ﹤0.01% 3488
2017
Q2 		$770K Sell
48,916
-4,657
-9% -$67.1K ﹤0.01% 3310
2017
Q1 		$739K Buy
53,573
+14,498
+37% +$203K ﹤0.01% 3328
2016
Q4 		$691K Buy
39,075
+5,581
+17% +$98K ﹤0.01% 3471
2016
Q3 		$645K Sell
33,494
-11,005
-25% -$215K ﹤0.01% 3501
2016
Q2 		$867K Buy
44,499
+6,995
+19% +$137K ﹤0.01% 3238
2016
Q1 		$772K Sell
37,504
-1,627
-4% -$32.1K ﹤0.01% 3280
2015
Q4 		$804K Sell
39,131
-2,791
-7% -$53.5K ﹤0.01% 3314
2015
Q3 		$717K Sell
41,922
-7,209
-15% -$132K ﹤0.01% 3157
2015
Q2 		$916K Buy
49,131
+4,478
+10% +$83K ﹤0.01% 3001
2015
Q1 		$852K Sell
44,653
-69,383
-61% -$1.28M ﹤0.01% 3022
2014
Q4 		$1.88M Sell
114,036
-478,584
-81% -$8.21M ﹤0.01% 2390
2014
Q3 		$10.5M Sell
592,620
-6,958
-1% -$137K 0.01% 1185
2014
Q2 		$12.4M Sell
599,578
-9,516
-2% -$196K 0.01% 1088
2014
Q1 		$13.3M Sell
609,094
-87,619
-13% -$2.01M 0.01% 994
2013
Q4 		$18.5M Buy
696,713
+92
+0% +$2.26K 0.01% 840
2013
Q3 		$16.5M Buy
696,621
+83,524
+14% +$1.95M 0.01% 842
2013
Q2 		$13.2M Buy
+613,097
New +$13.2M 0.01% 896

Other funds holding VIVO

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Royal Bank of Canada's VIVO Position: Q1 2023 in Review

Royal Bank of Canada sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 16,910 shares — an estimated $562K sold.

Royal Bank of Canada first reported a position in VIVO in Q2 2013 and held it in 39 quarters. The position peaked at $18.5M in Q4 2013. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

  • Royal Bank of Canada reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
  • Royal Bank of Canada sold 16,910 Meridian Bioscience Inc shares in Q1 2023, an estimated $562K.
  • Royal Bank of Canada first reported a position in Meridian Bioscience Inc in Q2 2013 and held it in 39 quarters.
  • Royal Bank of Canada's Meridian Bioscience Inc position peaked at $18.5M in Q4 2013.
  • 2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Royal Bank of Canada's 13F filing for Q1 2023, filed 15 May 2023.